K181738 is an FDA 510(k) clearance for the Medline ReNewal Reprocessed OxiMax Pulse Oximetry Sensors. Classified as Oximeter (product code DQA), Class II - Special Controls.
Submitted by Surgical Instrument Service and Savings Inc (Dba Medline (Redmond, US). The FDA issued a Cleared decision on March 22, 2019 after a review of 263 days - an extended review cycle.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.